PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine and Medical Specialties, Universidad de Alcalá, Madrid, Spain.\', \'Respiratory Medicine, Hospital Universitario de Guadalajara, Guadalajara, Spain.\', \'Respiratory Medicine, 16517Hospital Universitario de La Princesa, Madrid, Spain.\', \'Universidad Autónoma de Madrid, Madrid, Spain.\', \'Respiratory Diseases Networking Biomedical Research Centre (CIBERES), Institute of Health Carlos III (ISCIII), Madrid, Spain.\', \'SAVANA.\', \'16768Universidad Pontificia Comillas-IIT, Madrid, Spain.\', \'Respiratory Medicine, 16269Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/00368504221074574
?:doi
?:hasPublicationType
?:journal
  • Science progress
is ?:pmid of
?:pmid
?:pmid
  • 35084258
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.351
?:rankingScore_hIndex
  • 29
is ?:relation_isRelatedTo_publication of
?:title
  • Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35084258>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35084258>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all